287 research outputs found

    Phenolic compounds and antioxidant activities in some fruits and vegetables from Burkina Faso

    Get PDF
    Levels of total phenolic compounds (TPC), proanthocyanidins (PAs) and antioxidant activities among sixteen fruits and vegetables commonly consumed in Burkina Faso were determined. Levels of TPC ranged from 0.21 to 3.33 mg of gallic acid equivalent per gram of fresh matter. The highest contents in TPC were found in hot chili pepper, okra, lemon, spinach, onion, while the highest contents in PAs were found in spinach (3.52 mg), onion (2.35 mg), okra (1.27 mg), hot chili pepper (1.11 mg), tomato (0.54 mg) and garlic (0.46 mg). Antioxidant activities ranged from 0 to 9 ÎŒmol per gram of fresh weight, trolox equivalent antioxidant capacity (TEAC). The highest values of TEAC were found in garlic (9.6 ÎŒmol), okra (3 ÎŒmol), spinach (2.2 ÎŒmol), tamarind (2.2 ÎŒmol) and onion (2.1 ÎŒmol). These data revealed that, some local fruits and vegetables from Burkina Faso are potential sources of bioactive compounds.Key words: Antioxidant activity, phenolic compounds, fruits, vegetables, Burkina Faso

    Modalites de consommation et valeur nutritionnelle des legumineuses alimentaires au Burkina Faso

    Get PDF
    Au Burkina Faso les lĂ©gumineuses constituent une source importante de nutriments pour les populations. La prĂ©sente Ă©tude a eu pour objectif de dĂ©terminer la valeur nutritionnelle et la place des lĂ©gumineuses dans le rĂ©gime alimentaire des mĂ©nages Ă  Ouagadougou, Kaya, Lebda et NobĂ©rĂ©. La mĂ©thodologie a consistĂ© en une enquĂȘte de consommation alimentaire auprĂšs de 325 mĂ©nages et Ă  dĂ©terminer les teneurs en macronutriments et en minĂ©raux fer, zinc et calcium de six (6) variĂ©tĂ©s de lĂ©gumineuses. Il en rĂ©sulte que les principales lĂ©gumineuses consommĂ©es dans les mĂ©nages sont l’arachide (Arachis hypogea L.), le niĂ©bĂ© (Vigna unguiculata L.), le voandzou (Vigna subterranea L.), le soja (Glycine max L.) et le zamnĂš (Acacia macrostachya R.). L’arachide, le niĂ©bĂ© et le voandzou sont consommĂ©es plus 2 Ă  4 fois dans le mois par l’ensemble des mĂ©nages sous forme de mets au sein des mĂ©nages tandis que le soja et le zamnĂš sont consommĂ©s hors mĂ©nage. A l’exception du voandzou qui est consommĂ© au dĂ©jeuner par 38,30% des mĂ©nages Ă  Ouagadougou, 60% Ă  Kaya, 66,67% Ă  Lebda et 43,18% Ă  NobĂ©rĂ©, les autres lĂ©gumineuses sont consommĂ©es Ă  tout moment de la journĂ©e par plus de 80 % des mĂ©nages enquĂȘtĂ©s. Les lĂ©gumineuses niĂ©bĂ©, voandzou et zamnĂš sont consommĂ©es sous forme de ragout et de plats associĂ©s Ă  des cĂ©rĂ©ales respectivement par 99%, 93% et 76%. L’arachide et le soja sont utilisĂ©s comme des ingrĂ©dients ou comme des collations. Les lĂ©gumineuses ont des teneurs importantes en protĂ©ines, 35,76%, 31,04%, 27,29%, 22,55% et 20,38% respectivement pour le zamnĂš, le soja, l’arachide, le niĂ©bĂ© et le voandzou. Les teneurs en lipides sont faibles et contribuent Ă  moins de 7% Ă  la valeur Ă©nergĂ©tique. Le niĂ©bĂ© et le voandzou ont des teneurs en carbohydrates Ă©levĂ©es, prĂšs de 60%. Les teneurs en fer des lĂ©gumineuses varient de 1,77 mg/100g (voandzou) Ă  6,50 mg/100g (soja). Celles en zinc varient de 5,34 mg/100 g (zamnĂš) Ă  4,33 mg/100g (soja). Le soja et le zamnĂš ont d’importantes teneurs en calcium, respectivement 57,42 mg/100g et 68,40 mg/100g. Du fait de leur valeur nutritionnelle intĂ©ressante en micronutriments ces deux lĂ©gumineuses nĂ©cessitent une attention particuliĂšre pour l’enrichissement des produits locaux. La diversification des produits issus de ces lĂ©gumineuses ainsi que celle des mĂ©thodes de consommation au sein des mĂ©nages permettront un meilleur profilage de leur bĂ©nĂ©fice nutritionnel auprĂšs des populations.Mots clĂ©s: LĂ©gumineuses, importance, consommation, mĂ©nages, nutriments, urbain, rural, Burkina Fas

    ORAL LESIONS OF HIV-INFECTED CHILDREN IN WEST AFRICA IN THE ERA OF ANTIRETROVIRAL TREATMENTS

    Get PDF
    Oral Communication presented at the "Forum des Jeunes Chercheurs", Brest (France) 2011

    Near-forward Raman selection rules of the phonon-polariton created by alloying in (Zn,Be)Se

    Full text link
    The Raman selection rules of the (ZnSe, BeSe) mixed phonon polariton created by alloying in the three mode (1ZnSe, 2BeSe) ZnBeSe system, whose dramatic S like dispersion covers the large frequency gap between the ZnSe and BeSe spectral ranges, is studied in its wave vector dependence by near forward scattering. Both the collapse regime away from the Brillouin zone centre and the reinforcement regime near the Brillouin zone centre are addressed, using appropriate laser lines and Be contents. We find that in both regimes the considered phonon polariton, in fact a transverse mode with mixed mechanical and electrical character, obeys the same nominal Raman selection rules as its purely mechanical variant commonly observed in the backscattering geometry. Besides, marked differences in the phonon polariton Raman lineshapes in the two regimes give a hint about how the phonon polariton electrical field E develops while descending the S like dispersion towards the Brillouin zone centre. In the reinforcement regime E is large, leading to intramode on top of intermode transfers of oscillator strength mediated by E between the two BeSe modes, that both exhibit a fine structure on account of the alloy disorder. In contrast, in the collapse regime E remains weak, as testified by the absence of intramode transfer. The discussion is supported by contour modeling of the multi phonon polariton Raman lineshapes in their wave vector dependence within the linear dielectric approach.Comment: 16 pages, 7 figure

    Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Even though the efficacy of Intermittent Preventive Treatment in infants (IPTi) with Sulfadoxine-Pyrimethamine (SP) against clinical disease and the absence of its interaction with routine vaccines of the Expanded Immunization Programme (EPI) have been established, there are still some concerns regarding the addition of IPTi, which may increase the work burden and disrupt the routine EPI services especially in Africa where the target immunization coverage remains to be met. However IPTi may also increase the adherence of the community to EPI services and improve EPI coverage, once the benefice of strategy is perceived.</p> <p>Methods</p> <p>To assess the impact of IPTi implementation on the coverage of EPI vaccines, 22 health areas of the district of Kolokani were randomized at a 1:1 ratio to either receive IPTi-SP or to serve as a control. The EPI vaccines coverage was assessed using cross-sectional surveys at baseline in November 2006 and after one year of IPTi pilot-implementation in December 2007.</p> <p>Results</p> <p>At baseline, the proportion of children of 9-23 months who were completely vaccinated (defined as children who received BGG, 3 doses of DTP/Polio, measles and yellow fever vaccines) was 36.7% (95% CI 25.3% -48.0%). After one year of implementation of IPTi-SP using routine health services, the proportion of children completely vaccinated rose to 53.8% in the non intervention zone and 69.5% in the IPTi intervention zone (P <0.001).</p> <p>The proportion of children in the target age groups who received IPTi with each of the 3 vaccinations DTP2, DTP3 and Measles, were 89.2% (95% CI 85.9%-92.0%), 91.0% (95% CI 87.6% -93.7%) and 77.4% (95% CI 70.7%-83.2%) respectively. The corresponding figures in non intervention zone were 2.3% (95% CI 0.9% -4.7%), 2.6% (95% CI 1.0% -5.6%) and 1.7% (95% CI 0.4% - 4.9%).</p> <p>Conclusion</p> <p>This study shows that high coverage of the IPTi can be obtained when the strategy is implemented using routine health services and implementation results in a significant increase in coverage of EPI vaccines in the district of Kolokani, Mali.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov <a href="http://www.clinicaltrials.gov/ct2/show/NCT00766662">NCT00766662</a></p

    Hodgkin Lymphoma at the Paediatric Oncology Unit of Gabriel Touré Teaching Hospital, Bamako, Mali: 5-Year Experience

    Get PDF
    Introduction. The aim of this retrospective, unicentric study over 5 years is to describe the epidemiologic, pathologic, clinic and therapeutic aspects of children treated for Hodgkin lymphoma in our paediatric oncology unit. Patients and Methods. From January 2005 to December 2009, all children under 18 years of age, with Hodgkin lymphoma were included in this study. The treatment protocol was the GFAOP (Groupe Franco—Africain d'Oncologie PĂ©diatrique) Hodgkin lymphoma treatment protocol. Results. During the study period, 217 cancer cases were diagnosed in our centre. Of these cases, 7 were Hodgkin Lymphoma (LH) (0.04%). The mean age was 11.7 years. The sex-ratio was 6/1. 4% (5/7) of patients were stage IIB and 28.6% (2/7) stage IIIB of Ann-Arbor classification. There were 3 cases (42.8%) of sclero-nodular subtype, 2 cases (28.6%) of lymphocyte-rich classical HL subtype, 1 case (14.3%) of mixed cellularity and 1 case (14.3%) of lymphocyte depleted subtype. With a median followup of 37 months, 5 patients (71.4%) are alive, and 2 patients (28.6%) died. Conclusion. Broader multicentric studies are needed for more accurate data on this malignancy

    L’epilepsie en milieu scolaire : enquete chez les enseignants de la ville de Kati au Mali et revue de la litterature

    Get PDF
    Introduction La prĂ©valence de l’épilepsie en Afrique subsaharienne est Ă©levĂ©e. Nous avons menĂ© une Ă©tude transversale et descriptive dans l’ensemble des Ă©coles primaires de la ville de Kati (200 000 habitants). Les enseignants furent interviewĂ©s de maniĂšre exhaustive Ă  l’aide de questionnaires portant, d’une part, sur les connaissances, attitudes et pratiques des enseignants en matiĂšre d’épilepsie et, d’autre part, sur leurs avis sur les consĂ©quences psychologiques, sociales pour l’enfant Ă©pileptique et les incidences sur sa scolaritĂ©.RĂ©sultats Nous avons interrogĂ© 92 enseignants (60 hommes et 32 femmes). L’ñge moyen des enseignants Ă©tait de 30 ans. La majoritĂ© d’entre eux avait une expĂ©rience professionnelle de plus de 5 ans. Environ 38% des enseignants attribuaient la maladie Ă  une cause surnaturelle. Plus de 39% des enseignants pensaient que l’épilepsie Ă©tait contagieuse et 61% pensaient que l’épilepsie Ă©tait incurable. 79% interdisaient systĂ©matiquement la pratique du sport Ă  l’enfant Ă©pileptique. Environ 55% pensaient que l’enfant Ă©pileptique avait des capacitĂ©s cognitives infĂ©rieures Ă  celles de l’enfant non Ă©pileptique et 88% affirmaient que l’enfant épileptique Ă©tait incapable d’avoir une scolaritĂ© normale. 59% trouvaient que l’élĂšve Ă©pileptique Ă©tait victime de stigmatisation et de marginalisation. Devant une crise, 68% renvoyaient l’enfant au domicile.Conclusion Ce travail fait apparaĂźtre un besoin de formation des enseignants en matiĂšre d’épilepsie. Les donnĂ©es actuelles sur la frĂ©quence de l’épilepsie en milieu scolaire justifient une attention particuliĂšre des services de santĂ© et de ceux de l’éducation nationale sur la scolarisation de l’enfant Ă©pileptique.Mots clĂ©s : Epilepsie, Ecole, Enseignants, Mali, Pratiques

    Differential Scanning Fluorimetry provides high throughput data on silk protein transitions

    Get PDF
    Here we present a set of measurements using Differential Scanning Fluorimetry (DSF) as an inexpensive, high throughput screening method to investigate the folding of silk protein molecules as they abandon their first native melt conformation, dehydrate and denature into their final solid filament conformation. Our first data and analyses comparing silks from spiders, mulberry and wild silkworms as well as reconstituted ‘silk’ fibroin show that DSF can provide valuable insights into details of silk denaturation processes that might be active during spinning. We conclude that this technique and technology offers a powerful and novel tool to analyse silk protein transitions in detail by allowing many changes to the silk solutions to be tested rapidly with microliter scale sample sizes. Such transition mechanisms will lead to important generic insights into the folding patterns not only of silks but also of other fibrous protein (bio)polymers

    Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali

    Get PDF
    Background: Artemether–lumefantrine is widely used for uncomplicated Plasmodium falciparum malaria; sulfadoxine–pyrimethamine plus amodiaquine is used for seasonal malaria chemoprevention. We aimed to determine the efficacy of artemether–lumefantrine with and without primaquine and sulfadoxine–pyrimethamine plus amodiaquine with and without tafenoquine for reducing gametocyte carriage and transmission to mosquitoes. Methods: In this phase 2, single-blind, randomised clinical trial conducted in Ouelessebougou, Mali, asymptomatic individuals aged 10–50 years with P falciparum gametocytaemia were recruited from the community and randomly assigned (1:1:1:1) to receive either artemether–lumefantrine, artemether–lumefantrine with a single dose of 0·25 mg/kg primaquine, sulfadoxine–pyrimethamine plus amodiaquine, or sulfadoxine–pyrimethamine plus amodiaquine with a single dose of 1·66 mg/kg tafenoquine. All trial staff other than the pharmacist were masked to group allocation. Participants were not masked to group allocation. Randomisation was done with a computer-generated randomisation list and concealed with sealed, opaque envelopes. The primary outcome was the median within-person percent change in mosquito infection rate in infectious individuals from baseline to day 2 (artemether–lumefantrine groups) or day 7 (sulfadoxine–pyrimethamine plus amodiaquine groups) after treatment, assessed by direct membrane feeding assay. All participants who received any trial drug were included in the safety analysis. This study is registered with ClinicalTrials.gov, NCT05081089. Findings: Between Oct 13 and Dec 16, 2021, 1290 individuals were screened and 80 were enrolled and randomly assigned to one of the four treatment groups (20 per group). The median age of participants was 13 (IQR 11–20); 37 (46%) of 80 participants were female and 43 (54%) were male. In individuals who were infectious before treatment, the median percentage reduction in mosquito infection rate 2 days after treatment was 100·0% (IQR 100·0–100·0; n=19; p=0·0011) with artemether–lumefantrine and 100·0% (100·0–100·0; n=19; p=0·0001) with artemether–lumefantrine with primaquine. Only two individuals who were infectious at baseline infected mosquitoes on day 2 after artemether–lumefantrine and none at day 5. By contrast, the median percentage reduction in mosquito infection rate 7 days after treatment was 63·6% (IQR 0·0–100·0; n=20; p=0·013) with sulfadoxine–pyrimethamine plus amodiaquine and 100% (100·0–100·0; n=19; p<0·0001) with sulfadoxine–pyrimethamine plus amodiaquine with tafenoquine. No grade 3–4 or serious adverse events occurred. Interpretation: These data support the effectiveness of artemether–lumefantrine alone for preventing nearly all mosquito infections. By contrast, there was considerable post-treatment transmission after sulfadoxine–pyrimethamine plus amodiaquine; therefore, the addition of a transmission-blocking drug might be beneficial in maximising its community impact. Funding: Bill & Melinda Gates Foundation
    • 

    corecore